Get in touch
Contact Safe BPC-157
For editorial questions and corrections to our reading of the BPC-157 literature.
Editorial inquiries
Use the form below to reach Safe BPC-157 about the content of this site. Corrections are welcome — if you think a study has been misread, a finding overstated, or a citation attached to the wrong source, name the page and the reference and it will be checked back against the original. On a bench whose only value is accuracy, a well-aimed correction helps every reader who arrives after you.
What the bench cannot do is anything clinical or commercial. It keeps no consulting room and no stockroom: no judgment on whether anyone should use this peptide, no dose to recommend, no BPC-157 or any other compound to sell, supply, or point you toward. Questions of that kind belong with a licensed healthcare professional, who can weigh an individual situation in a way a reading of the literature never can.
What to include
A useful message names the page, quotes the sentence or citation in question, and links the source you think we should have used. Specific, sourced corrections get the fastest and most useful response, because they let us check our reading against the same evidence you are looking at.
If you are a researcher or clinician who believes a finding has been superseded by newer work, a link to the newer paper is the single most helpful thing you can send. We update our reading of the literature when the literature moves.
We read every message but cannot guarantee a reply to general questions already answered on the research, dosage, FAQ, or legal status pages. Requests for medical guidance, dosing, or sourcing will not be answered, because providing them is outside what this editorial project does.
Contact form
A simple contact form follows, with fields for name, email, the page or citation you are writing about, and your message. Submissions are treated as editorial correspondence only.